Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.691/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691 |
Version | 20231019 |
Status | active |
Date | 2023-10-19T01:11:23-04:00 |
Name | PIM_Glyxambi |
Title | PIM_Glyxambi |
Experimental | False |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: Medications containing Glyxambi in different strengths),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC),(Inclusion Criteria: includes both brand and generic of Empagliflozin/Linagliptin combination),(Exclusion Criteria: Single ingredient drugs of Empagliflozin and Linagliptin) |
No resources found
CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1078.691",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "Optum Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2023-10-19"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2023-10-19"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1078.691"
}
],
"version" : "20231019",
"name" : "PIM_Glyxambi",
"title" : "PIM_Glyxambi",
"status" : "active",
"date" : "2023-10-19T01:11:23-04:00",
"publisher" : "Optum Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: Medications containing Glyxambi in different strengths),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC),(Inclusion Criteria: includes both brand and generic of Empagliflozin/Linagliptin combination),(Exclusion Criteria: Single ingredient drugs of Empagliflozin and Linagliptin)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1151131",
"display" : "Oral Product"
},
{
"code" : "1151133",
"display" : "Pill"
},
{
"code" : "1598392",
"display" : "empagliflozin / linagliptin"
},
{
"code" : "1602106",
"display" : "empagliflozin / linagliptin Oral Product"
},
{
"code" : "1602107",
"display" : "empagliflozin / linagliptin Pill"
},
{
"code" : "1602108",
"display" : "empagliflozin / linagliptin Oral Tablet"
},
{
"code" : "1602109",
"display" : "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet"
},
{
"code" : "1602110",
"display" : "Glyxambi"
},
{
"code" : "1602111",
"display" : "empagliflozin 10 MG / linagliptin 5 MG [Glyxambi]"
},
{
"code" : "1602112",
"display" : "empagliflozin / linagliptin Oral Tablet [Glyxambi]"
},
{
"code" : "1602113",
"display" : "Glyxambi Oral Product"
},
{
"code" : "1602114",
"display" : "Glyxambi Pill"
},
{
"code" : "1602115",
"display" : "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]"
},
{
"code" : "1602118",
"display" : "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet"
},
{
"code" : "1602119",
"display" : "empagliflozin 25 MG / linagliptin 5 MG [Glyxambi]"
},
{
"code" : "1602120",
"display" : "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet [Glyxambi]"
},
{
"code" : "317541",
"display" : "Oral Tablet"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:e4adcd8b-f9e9-4ce5-bd5f-0c39f3bf521e",
"timestamp" : "2024-12-10T05:46:32-05:00",
"total" : 17,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1151131",
"display" : "Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1151133",
"display" : "Pill"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1598392",
"display" : "empagliflozin / linagliptin"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602106",
"display" : "empagliflozin / linagliptin Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602107",
"display" : "empagliflozin / linagliptin Pill"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602108",
"display" : "empagliflozin / linagliptin Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602109",
"display" : "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602110",
"display" : "Glyxambi"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602111",
"display" : "empagliflozin 10 MG / linagliptin 5 MG [Glyxambi]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602112",
"display" : "empagliflozin / linagliptin Oral Tablet [Glyxambi]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602113",
"display" : "Glyxambi Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602114",
"display" : "Glyxambi Pill"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602115",
"display" : "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602118",
"display" : "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602119",
"display" : "empagliflozin 25 MG / linagliptin 5 MG [Glyxambi]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1602120",
"display" : "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet [Glyxambi]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "317541",
"display" : "Oral Tablet"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.